CELEGHINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 7.026
EU - Europa 2.914
AS - Asia 2.807
SA - Sud America 221
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 13.034
Nazione #
US - Stati Uniti d'America 6.967
SG - Singapore 1.074
PL - Polonia 804
CN - Cina 746
UA - Ucraina 440
SE - Svezia 408
HK - Hong Kong 282
IT - Italia 252
VN - Vietnam 226
FI - Finlandia 196
BR - Brasile 165
KR - Corea 156
TR - Turchia 153
GB - Regno Unito 143
FR - Francia 138
DE - Germania 113
RU - Federazione Russa 108
IE - Irlanda 87
BG - Bulgaria 72
CH - Svizzera 67
IN - India 47
CA - Canada 31
BE - Belgio 20
NL - Olanda 20
MA - Marocco 19
MX - Messico 19
IQ - Iraq 18
AR - Argentina 17
BD - Bangladesh 16
GR - Grecia 14
JP - Giappone 13
ID - Indonesia 12
CL - Cile 11
ES - Italia 9
PH - Filippine 8
ZA - Sudafrica 8
AT - Austria 7
CO - Colombia 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
KE - Kenya 5
PY - Paraguay 5
TH - Thailandia 5
UZ - Uzbekistan 5
AM - Armenia 4
AU - Australia 4
EC - Ecuador 4
EU - Europa 4
PE - Perù 4
SN - Senegal 4
UY - Uruguay 4
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
TN - Tunisia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 13.034
Città #
Fairfield 838
Woodbridge 737
Warsaw 732
Ashburn 623
Singapore 607
Ann Arbor 535
Houston 512
Chandler 415
Jacksonville 397
Wilmington 351
Seattle 334
Hong Kong 280
Cambridge 273
San Jose 235
Hefei 202
Seoul 153
Princeton 144
Izmir 139
Boardman 137
Beijing 132
Dallas 115
Chicago 91
Columbus 73
Dublin 72
Sofia 72
Lauterbourg 67
Zgierz 66
Helsinki 65
Bern 62
Trieste 62
Ho Chi Minh City 59
Hanoi 54
Moscow 54
Los Angeles 52
Buffalo 47
San Diego 46
Dearborn 43
The Dalles 43
Frankfurt am Main 41
Menlo Park 31
Santa Clara 28
Milan 27
New York 23
Des Moines 22
Nanjing 21
São Paulo 20
London 19
Guangzhou 18
Shanghai 18
Falls Church 16
Verona 16
Brussels 15
Casablanca 15
Ferrara 14
Orem 13
Jinan 12
Council Bluffs 11
Hangzhou 11
Phoenix 11
Tokyo 11
Corinth 10
Da Nang 10
Denver 10
Dong Ket 10
Redwood City 10
Atlanta 9
Auburn Hills 9
Brooklyn 9
Düsseldorf 9
Kunming 9
Norwalk 9
Nanchang 8
Redondo Beach 8
Washington 8
Amsterdam 7
Baghdad 7
Haiphong 7
Mexico City 7
Montreal 7
Sacile 7
Shenzhen 7
Tianjin 7
Vancouver 7
Xi'an 7
Chennai 6
Johannesburg 6
Portsmouth 6
Zhengzhou 6
Boston 5
Hebei 5
Kocaeli 5
Mumbai 5
North Bergen 5
Poplar 5
Santiago 5
Shenyang 5
Tappahannock 5
Tashkent 5
Toronto 5
Ankara 4
Totale 9.613
Nome #
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 439
Neuronal Dysfunction Associated with Cholesterol Deregulation. 426
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 378
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 350
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 339
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 303
Pre-eclampsia affects procalcitonin production in placental tissue 302
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 261
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 248
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 247
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 222
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 220
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 220
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 220
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 212
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 206
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. 203
Potential role of circulating microRNAs as early markers of preeclampsia 199
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 199
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. 197
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 197
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 194
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-Rays absorptiometry 190
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. 189
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 188
Potential pathogenetic implications of cyclooxygenase-2 overexpression in Bchronic lymphoid leukemia cells 184
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 184
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity 182
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. 178
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 178
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 173
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 172
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. 169
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. 168
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 166
Recent advances in the therapeutic perspectives of Nutlin-3 165
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 164
PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 163
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 162
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells 161
Differential effects of stromal derived factor-1a (SDF-1a) on early and late stages of human megakaryocytic development. 157
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 155
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 155
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL). 155
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 155
In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. 154
Thrombopoietin enhances the aIIbb3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. 149
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. 149
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. 149
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 147
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. 145
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. 141
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 141
In vitro senescence and apoptotic cell death of human megakaryocytes. 140
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line. 139
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 139
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. 138
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 136
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 134
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 133
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells. 129
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. 129
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 128
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 126
NF-κB pathways in hematological malignancies 119
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 116
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 114
The engagement of CD4 surface antigen in the HEL haemopoietic cell line up-regulates the transforming growth factor-b1 (TGF-b1) promoter activity. 113
Levels of circulating TNF‑related apoptosis‑inducing ligand in celiac disease 107
In situ polymerase chain reaction tecnique revealed by flow cytometry as a tool for gene detection. 105
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. 102
Morphological features of apoptosis in hematopoietic cells belonging to the T-lymphoid and myeloid lineages. 98
Totale 13.215
Categoria #
all - tutte 35.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 0 0 0 0 135 38 121
2021/2022792 37 51 32 67 31 80 44 23 97 91 74 165
2022/20231.166 94 125 84 170 118 231 1 108 172 6 44 13
2023/2024627 93 48 37 55 48 52 120 101 5 5 30 33
2024/20251.272 20 29 65 183 132 169 42 76 171 121 93 171
2025/20262.964 252 198 288 229 258 351 566 124 384 314 0 0
Totale 13.215